Troy A. Ignelzi - Feb 15, 2022 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Financial Officer
Signature
/s/ Troy Ignelzi
Stock symbol
KRTX
Transactions as of
Feb 15, 2022
Transactions value $
-$152,910
Form type
4
Date filed
2/17/2022, 04:21 PM
Previous filing
Jan 6, 2022
Next filing
Apr 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $13.8K +1.5K +6.01% $9.20* 26.5K Feb 15, 2022 Direct
transaction KRTX Common Stock Sale -$167K -1.5K -5.67% $111.14 25K Feb 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -1.5K -0.94% $0.00 159K Feb 15, 2022 Common Stock 1.5K $9.20 Direct F2
transaction KRTX Option (right to buy) Award $0 +48.5K $0.00 48.5K Feb 16, 2022 Common Stock 48.5K $111.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.
F2 This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2019, with additional vesting as to 12.5% of the shares underlying the option award on each six month period thereafter.
F3 25% of the options shall vest on February 16, 2023, and the remaining options shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.